Search Results

5 articles with title/keywords/abstract containing Orexigen-Therapeutics

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
modify search
Display per page 

Bupropion/zonisamide SR has potential in obesity

Source: Inpharma, Volume 1, Number 1620, 2008-01-12 , pp. 20-20(1)

Publisher: Adis International

Naltrexone/bupropion: substantial benefits in obese patients

Source: Inpharma, Volume 1, Number 1612, 2007-11-03 , pp. 13-13(1)

Publisher: Adis International

The fixed combination bupropion/zonisamide [Empatic] has shown significant weight loss results in obese patients

Source: Inpharma, Volume 1, Number 1601, 2007-08-18 , pp. 8-8(1)

Publisher: Adis International

Bupropion/zonisamide is effective for weight loss in obese patients

Source: Inpharma, Volume 1, Number 1561, 2006-10-28 , pp. 6-6(1)

Publisher: Adis International

Naltrexone/bupropion is showing promise as a treatment for obesity

Source: Inpharma, Volume 1, Number 1558, 2006-10-07 , pp. 6-6(1)

Publisher: Adis International

modify search
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A